Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGLT2 Inhibitors in Moderate Aortic Stenosis
NCT06469645Phase 3Completed
- Sponsor
- University of East Anglia
- Start
- May 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in aortic valve stenosis, sponsored by University of East Anglia. Started May 2024; status: completed.
02
Drugs
empagliflozin
03
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT06469645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06469645.